The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease

Author： Zangara A.  

Publisher： Elsevier

ISSN： 0091-3057

Source： Pharmacology Biochemistry and Behavior, Vol.75, Iss.3, 2003-06, pp. : 675-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on huperzine A as a treatment for Alzheimer's disease

By Little John T   Walsh Sally   Aisen Paul S  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 209-215

Informa Healthcare

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Microemulsion-based patch for transdermal delivery of huperzine A and ligustrazine phosphate in treatment of Alzheimer’s disease

By Shi Jun   Cong Wenjuan   Wang Yiming   Liu Qingfei   Luo Guoan  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 6, 2012-06 ,pp. : 752-761

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective Therapies for Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 705-717

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease

By  

Current Psychopharmacology, Vol. 3, Iss. 1, 2014-04 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite